JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gobaille, S.
Right arrow Articles by Maitre, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gobaille, S.
Right arrow Articles by Maitre, M.

Vol. 290, Issue 1, 303-309, July 1999

gamma -Hydroxybutyrate Modulates Synthesis and Extracellular Concentration of gamma -Aminobutyric Acid in Discrete Rat Brain Regions In Vivo1

Serge Gobaille, Viviane Hechler, Christian Andriamampandry, Véronique Kemmel and Michel Maitre

Laboratoire de Neurobiologie Moléculaire des Interactions Cellulaires, Centre National de la Recherche Scientifique, Institut de Chimie Biologique, Faculté de Médecine, Strasbourg Cedex, France

gamma -Hydroxybutyrate possesses most of the properties of a neurotransmitter/neuromodulator that acts via specific pathways and receptors in brain. Beside its regulatory effects on dopaminergic transmission, gamma -hydroxybutyrate was thought for many years to interfere with gamma -aminobutyric acid (GABA)ergic processes in the brain. The present study demonstrates that in the rat frontal cortex in vivo, gamma -hydroxybutyrate or its agonist NCS-356 administered systemically at a high dose (500 mg/kg) increases GABA contents in dialysates via a mechanism blocked by the peripheral administration of the gamma -hydroxybutyrate antagonist NCS-382. Under the same conditions, the extracellular concentration of this amino acid was not modified in the hippocampus. However, when administered at a low dose (250 mg/kg), gamma -hydroxybutyrate decreases GABA content of the dialysates of the frontal cortex by an NCS-382-sensitive mechanism. Spontaneous [3H]GABA release was observed in the frontal cortex of rats at 160 min after i.p. [3H]-gamma -hydroxybutyrate administration. This result indicates that gamma -hydroxybutyrate in vivo could be the precursor of an extracellular GABA pool in the frontal cortex. After i.p. [3H]-gamma -hydroxybutyrate administration in the rat, the amino acid contents of several brain regions were quantified 160 min later, and the radioactivity in each region was measured. [3H]GABA, [3H]glutamate, and [3H]glycine were detected in most, but not all, of the brain regions studied. In particular, radioactive GABA was not detected in the hippocampus. The other amino acids were not labeled. These results show that gamma -hydroxybutyrate modulates the synthesis and the extracellular concentrations of GABA in specific regions of the rat brain. Identification of these GABA pools and determination of their functional role remain to be defined.


0022-3565/99/2901-0303$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurosci.Home page
E. Sanna, M. C. Mostallino, F. Busonero, G. Talani, S. Tranquilli, M. Mameli, S. Spiga, P. Follesa, and G. Biggio
Changes in GABAA Receptor Gene Expression Associated with Selective Alterations in Receptor Function and Pharmacology after Ethanol Withdrawal
J. Neurosci., December 17, 2003; 23(37): 11711 - 11724.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Ren and I. Mody
{gamma}-Hydroxybutyrate Reduces Mitogen-activated Protein Kinase Phosphorylation via GABAB Receptor Activation in Mouse Frontal Cortex and Hippocampus
J. Biol. Chem., October 24, 2003; 278(43): 42006 - 42011.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Follesa, L. Mancuso, F. Biggio, M. C. Mostallino, A. Manca, M. P. Mascia, F. Busonero, G. Talani, E. Sanna, and G. Biggio
gamma -Hydroxybutyric Acid and Diazepam Antagonize a Rapid Increase in GABAA Receptors alpha 4 Subunit mRNA Abundance Induced by Ethanol Withdrawal in Cerebellar Granule Cells
Mol. Pharmacol., April 1, 2003; 63(4): 896 - 907.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. K. Mehta, N. M. Muschaweck, D. Y. Maeda, A. Coop, and M. K. Ticku
Binding Characteristics of the gamma -Hydroxybutyric Acid Receptor Antagonist [3H](2E)-(5-Hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) Ethanoic Acid in the Rat Brain
J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 1148 - 1153.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.